Related Experiment Video
Updated: Jun 25, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Genome-wide association study for type 2 diabetes: clinical applications
Valeriya Lyssenko1, Leif Groop
1Department of Clinical Sciences/Diabetes & Endocrinology and Lund University Diabetes Centre, Lund University, University Hospital Malmö, Malmö, Sweden. Valeri.Lyssenko@med.lu.se
Current Opinion in Lipidology
|March 12, 2009
Summary
Recent advances in type 2 diabetes genetics have identified new common variants influencing beta-cell function. While genetic insights are improving disease understanding, genetic testing for personalized risk prediction is not yet available.
Area of Science:
- Genetics
- Metabolic Diseases
- Endocrinology
Background:
- Complex polygenic diseases like type 2 diabetes involve interactions between genetic variants and environmental factors.
- Understanding the genetic basis of type 2 diabetes is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To review recent advancements in the genetics of type 2 diabetes.
- To provide insights into novel genetic discoveries and their implications for disease pathogenesis.
Main Methods:
- Genome-wide association studies (GWAS) have been instrumental in identifying common genetic variants associated with type 2 diabetes.
- Analysis of large-scale genetic data from consortia has accelerated the discovery of susceptibility loci.
Main Results:
- Nineteen common variants associated with type 2 diabetes susceptibility were identified in the past year.
- These novel genetic loci primarily affect beta-cell function, influencing insulin secretion in response to insulin resistance and body weight.
- The role of rare variants and copy number variations in type 2 diabetes pathogenesis is an emerging area of research.
Conclusions:
- Significant progress in type 2 diabetes genetics has enhanced our understanding of disease mechanisms.
- These genetic discoveries offer promising avenues for future drug development and therapeutic interventions.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...